Q3 2023 Ophthalmology Update
The ophthalmology sector experienced sustained deal flow in the third quarter, although at a slower pace than in previous quarters. Provident attributes the slight slowdown in deal activity to tighter lending markets and more selective M&A strategies from existing platforms. PE-backed consolidators have been more strategic in who they align with, focusing on practices in adjacent markets or with significant geographic overlap.
Provident expects transaction volumes to pick back up in Q4 and in 2024, as lending markets soften, interest rate levels stabilize, and existing PE-backed platforms prepare for transaction processes of their own.
To print and download the full Ophthalmology Services Update report, please click below…
[holo_button icon=”/wp-content/uploads/2023/10/Q3-23-Ophthalmology.pdf”” color=”#003561″ target=”blank”]PRINT/DOWNLOAD[/holo_button]